Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
iPSC Vasculogenic Cell (Pulmonary Hypertension)
- Development stage
- Preclinical
- Lead developer
- Vascugen
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
iPSC Vasculogenic Cell (Pulmonary Hypertension) is an experimental cell therapy being developed by Vascugen for the treatment of pulmonary hypertension. The therapy utilizes induced pluripotent stem cells (iPSCs) that are differentiated into specialized vasculogenic cells designed to repair and regenerate damaged blood vessels. In the context of pulmonary hypertension, these cells are intended to restore the pulmonary microvasculature, thereby reducing pulmonary vascular resistance and improving overall lung and cardiac function. The program is being developed in collaboration with the Ottawa Hospital Research Institute and is currently in the research stage of development.
- Other names
- iPSC-derived vasculogenic cell therapyVascugen iPSC Vasculogenic Cell
Beyond the preview
Go deeper on iPSC Vasculogenic Cell (Pulmonary Hypertension).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iPSC Vasculogenic Cell (Pulmonary Hypertension).